期刊文献+

5-Fu肠腔化疗辅助结直肠癌根治术的应用及其机制探讨 被引量:2

Discussion on the application and mechanism of the radical cure therapy against colon cancer and recta cancer with the subservient 5-Fu chemotherapy of intestines cavity
下载PDF
导出
摘要 目的:探讨5-Fu肠腔化疗辅助结直肠癌根治术的应用及其机制。方法:总结我院1995年2月~2005年5月125例结直肠癌在根治术中辅助应用5-Fu肠腔化疗的临床资料。结果:本组125例无一例死亡,2例术后吻合口漏,经再次手术后治愈;96例随诊1~5年,失访29例,5年存活82例,其中并存肝转移者3例,骨转移者2例,5年生存率65.6%。结论:直肠癌根治术中辅助5-Fu肠腔化疗方法简便,效果明显,值得临床推广应用。 This paper aims to discuss the application and mechanism of the radical cure therapy against colon cancer and recta cancer with the subservient 5-Fu chemotherapy of intestines cavity. The method is as follows: to generalize clinic information of 125 cases of colon cancer and recta cancer from February, 1995 to May, 2005 in our hospital, which have adopted the radical cure therapy with subservient 5-Fu chemotherapy of intestines cavity. The result is as follows: no death in this 125-case group, 2 cases anastomosis and complete cure after a second operation; 96 cases for one -to- five year observation and treatment, 29 cases losing contact. There are 82 cases of 5 years' survival, among which are 3 cases transferring to liver and 2 cases transferring to bones. The five-year survival rate is 65.6 %. The conclusion is as follows: this therapy is simple and with remarked effect, so it is worth popularizing in clinic.
出处 《鄂州大学学报》 2006年第6期43-45,共3页 Journal of Ezhou University
关键词 5-FU 肠腔化疗 结直肠癌根治术 5-Fu chemotherapy of gut cavity the radical cure therapy against colon cancer and recta cancer
  • 相关文献

参考文献2

二级参考文献27

  • 1Chau I,Chan S,Cunningham D.Overview of preoperative and postoperative therapy for colorectal cancer:the European and United States perspectives.Clin Colorectal Cancer,2003,3(1):19-33.
  • 2Schuhmacher C,Fink U,Siewert JR.Preoperative downstaging in advanced stomach carcinoma.Wishful thinking or reality.Zentralbl Chir,2000,125(4):333-334.
  • 3Niederhuber JE.Neoadjuvant therapy.Ann Surg,1999,229(3):309-312.
  • 4Geh JI,Glynne Jones R,Kwok QS,et al.Preoperative ECF chemotherapy in gastro-oesophageal adenocarcinoma.Clin Oncol,2000,12(3):182-187.
  • 5Rustum YM,Harstrick A,Cao S,et al.Thymidylate synthase inhibitors in cancer therapy:direct and indirect inhibitors.J Clin Oncol,1997,15(1):389-400.
  • 6Andre T,Louvet C,de Gramont A.Colon cancer: what is new in 2004?Bull Cancer,2004,91(1):75-80.
  • 7Frena A,Martin F,La Guardia G,et al.Liver resection after downstaging with neoadjuvant chemotherapy for "unresectable" colorectal metastases.Chir Ital,2004,56(3):351-357.
  • 8Ong SY.Neoadjuvant chemotherapy in the management of colorectal metastases:A review of the literature.Ann Acad Med Singapore,2003,32(2):205-211.
  • 9Bathe OF,Dowden S,Sutherland F,et al.Phase Ⅱ study of neoadjuvant 5-FU+leucovorin+CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma.BMC Cancer,2004,4(1):32.
  • 10Negri F,Musolino A,Cunningham D,et al.Retrospective study of resection of pulmonary metastases in patients with advanced colorectal cancer:the development of a preoperative chemotherapy strategy.Clin Colorectal Cancer,2004,4(2):101-106.

共引文献68

同被引文献25

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部